Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS

View source ↗

Summary

A clinical trial evaluating the pathologic role of the gene IGLV1-44 in AL amyloidosis and POEMS syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: AL Amyloidosis, POEMS Syndrome | Status: RECRUITING